KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Interest & Investment Income (2016 - 2018)

Emergent BioSolutions (EBS) has 8 years of Interest & Investment Income data on record, last reported at $701000.0 in Q3 2018.

  • For Q3 2018, Interest & Investment Income rose 10.05% year-over-year to $701000.0; the TTM value through Sep 2018 reached $1.4 million, down 26.2%, while the annual FY2017 figure was $1.8 million, 66.48% up from the prior year.
  • Interest & Investment Income reached $701000.0 in Q3 2018 per EBS's latest filing, up from $306000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $701000.0 in Q3 2018 and bottomed at $31000.0 in Q2 2014.
  • Average Interest & Investment Income over 5 years is $259315.8, with a median of $220000.0 recorded in 2016.
  • Peak YoY movement for Interest & Investment Income: surged 955.56% in 2014, then plummeted 47.51% in 2018.
  • A 5-year view of Interest & Investment Income shows it stood at $190000.0 in 2014, then plummeted by 40.53% to $113000.0 in 2015, then skyrocketed by 155.75% to $289000.0 in 2016, then plummeted by 44.64% to $160000.0 in 2017, then soared by 338.12% to $701000.0 in 2018.
  • Per Business Quant database, its latest 3 readings for Interest & Investment Income were $701000.0 in Q3 2018, $306000.0 in Q2 2018, and $222000.0 in Q1 2018.